Dianthus Therapeutics (DNTH) Institutional Ownership $18.14 +0.94 (+5.47%) Closing price 04:00 PM EasternExtended Trading$18.16 +0.02 (+0.14%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Dianthus Therapeutics (NASDAQ:DNTH)CurrentInstitutional OwnershipPercentage47.53%Number ofInstitutional Buyers(last 12 months)54TotalInstitutional Inflows(last 12 months)$177.88MNumber ofInstitutional Sellers(last 12 months)33TotalInstitutional Outflows(last 12 months)$83.77M Get DNTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Dianthus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DNTH Institutional Buying and Selling by Quarter Dianthus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers35,045$636K0.0%-2.5%0.109% 5/16/2025 Octagon Capital Advisors LP2,341,667$42.48M4.5%+11.0%7.289% 5/16/2025 Goldman Sachs Group Inc.73,430$1.33M0.0%-64.7%0.229% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.15,334$280K0.0%+4.2%0.048% 5/16/2025 Alliancebernstein L.P.1,025,622$18.61M0.0%-11.6%3.192% 5/16/2025 Ally Bridge Group NY LLC80,584$1.46M1.3%-24.3%0.251% 5/16/2025 Adage Capital Partners GP L.L.C.189,000$3.43M0.0%+5.0%0.588% 5/16/2025 ADAR1 Capital Management LLC18,285$332K0.1%+3.4%0.057% 5/15/2025 Vestal Point Capital LP1,700,069$30.84M2.2%+58.1%5.292% 5/15/2025 RA Capital Management L.P.2,866,733$52.00M0.9%+53.6%8.923% Get the Latest News and Ratings for DNTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2025 Braidwell LP375,355$6.81M0.2%-68.9%1.168% 5/15/2025 Cubist Systematic Strategies LLC21,818$396K0.0%-60.2%0.068% 5/14/2025 Rafferty Asset Management LLC23,872$433K0.0%-16.1%0.074% 5/14/2025 Walleye Capital LLC106,931$1.94M0.0%+29.0%0.333% 5/14/2025 Candriam S.C.A.248,610$4.51M0.0%N/A0.774% 5/14/2025 Wellington Management Group LLP67,982$1.23M0.0%+12.7%0.212% 5/13/2025 American Century Companies Inc.47,817$867K0.0%+8.7%0.149% 5/12/2025 Nuveen LLC64,381$1.17M0.0%N/A0.200% 5/12/2025 Invesco Ltd.15,978$290K0.0%+38.7%0.050% 5/9/2025 Deutsche Bank AG17,896$325K0.0%-10.6%0.056% 5/9/2025 Charles Schwab Investment Management Inc.168,102$3.05M0.0%+0.6%0.523% 5/9/2025 Vanguard Group Inc.1,108,875$20.12M0.0%-13.0%3.452% 5/8/2025 US Bancorp DE1,585$29K0.0%+2,013.3%0.005% 4/29/2025 Bank of New York Mellon Corp73,638$1.34M0.0%+1.0%0.229% 4/29/2025 Moody Aldrich Partners LLC74,372$1.35M0.3%N/A0.232% 4/8/2025 Rhumbline Advisers35,045$636K0.0%-2.5%0.109% 4/7/2025 GAMMA Investing LLC3,882$70K0.0%+3,030.6%0.012% 3/24/2025 Wellington Management Group LLP60,337$1.32M0.0%+12.2%0.188% 3/18/2025 California State Teachers Retirement System8,055$176K0.0%-14.4%0.027% 2/17/2025 Woodline Partners LP300,504$6.55M0.0%+20.0%1.015% 2/17/2025 Vestal Point Capital LP1,075,000$23.44M1.4%+172.2%3.632% 2/17/2025 Squarepoint Ops LLC11,081$242K0.0%-26.9%0.037% 2/17/2025 Two Sigma Investments LP10,601$231K0.0%-5.3%0.036% 2/17/2025 Rafferty Asset Management LLC28,459$620K0.0%-7.1%0.096% 2/17/2025 Point72 Asset Management L.P.193,600$4.22M0.0%-55.8%0.654% 2/17/2025 Octagon Capital Advisors LP2,110,167$46.00M7.6%+20.8%7.129% 2/17/2025 Millennium Management LLC90,436$1.97M0.0%+160.2%0.306% 2/17/2025 Janus Henderson Group PLC1,085,648$23.61M0.0%+14.4%3.668% 2/17/2025 Deutsche Bank AG20,011$436K0.0%+55.9%0.068% 2/17/2025 Cubist Systematic Strategies LLC54,766$1.19M0.0%+9.0%0.185% Hedge fund legend humiliates Bitcoin traders (Ad)Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities.Now he’s revealing the entire thing… FREE.2/17/2025 Braidwell LP1,206,589$26.30M0.8%+144.4%4.076% 2/17/2025 Avidity Partners Management LP2,873,000$62.63M6.2%-1.5%9.706% 2/17/2025 Bank of America Corp DE78,173$1.70M0.0%-11.2%0.264% 2/17/2025 BNP Paribas Financial Markets2,695$59K0.0%N/A0.009% 2/17/2025 Allostery Investments LP25,000$545K0.6%N/A0.084% 2/17/2025 Ally Bridge Group NY LLC106,434$2.32M1.9%N/A0.360% 2/17/2025 5AM Venture Management LLC1,027,711$22.40M5.3%-16.6%3.472% 2/14/2025 RA Capital Management L.P.1,866,400$40.69M0.5%-20.0%6.305% 2/14/2025 TCG Crossover Management LLC1,501,624$32.74M3.2%N/A5.073% 2/14/2025 Northern Trust Corp245,523$5.35M0.0%+21.2%0.829% 2/14/2025 Adage Capital Partners GP L.L.C.180,000$3.92M0.0%N/A0.608% 2/14/2025 Price T Rowe Associates Inc. MD9,468$207K0.0%+21.1%0.032% 2/14/2025 Bain Capital Life Sciences Investors LLC2,689,707$58.64M6.9%-10.7%9.087% 2/14/2025 Tower Research Capital LLC TRC1,379$30K0.0%-40.6%0.005% 2/14/2025 MetLife Investment Management LLC14,372$313K0.0%+3.1%0.049% 2/13/2025 Walleye Capital LLC82,890$1.81M0.0%+176.3%0.280% 2/13/2025 Barclays PLC42,766$933K0.0%+2.6%0.144% 2/13/2025 Legal & General Group Plc12,319$269K0.0%+23.7%0.042% 2/13/2025 Invesco Ltd.11,521$251K0.0%+7.4%0.039% 2/13/2025 ADAR1 Capital Management LLC17,683$385K0.1%-85.1%0.060% 2/13/2025 FMR LLC4,439,281$96.78M0.0%+0.8%14.998% 2/13/2025 Rhenman & Partners Asset Management AB114,000$2.49M0.3%-24.0%0.385% 2/13/2025 Wells Fargo & Company MN13,818$301K0.0%-37.4%0.047% 2/12/2025 Geode Capital Management LLC486,263$10.60M0.0%+0.2%1.643% 2/12/2025 Alliancebernstein L.P.1,159,776$25.28M0.0%+13.4%3.918% 2/12/2025 Wellington Management Group LLP60,337$1.32M0.0%+12.2%0.204% 2/12/2025 JPMorgan Chase & Co.12,129$264K0.0%+14.0%0.041% 2/11/2025 Corebridge Financial Inc.11,883$259K0.0%-7.0%0.040% 2/11/2025 Vanguard Group Inc.1,274,638$27.79M0.0%-1.6%4.306% 2/11/2025 KLP Kapitalforvaltning AS1,500$33K0.0%N/A0.005% 2/11/2025 American Century Companies Inc.43,996$959K0.0%+3.8%0.149% 2/11/2025 Intech Investment Management LLC9,243$201K0.0%N/A0.031% 2/10/2025 Swiss National Bank14,400$314K0.0%-16.8%0.049% 2/7/2025 AlphaQuest LLC4,197$91K0.0%+273.1%0.014% 2/6/2025 Charles Schwab Investment Management Inc.167,021$3.64M0.0%+0.7%0.564% 1/30/2025 Rhumbline Advisers35,933$783K0.0%+3.8%0.121% 1/23/2025 R Squared Ltd1,200$26K0.0%N/A0.004% 1/22/2025 KBC Group NV1,593$35K0.0%N/A0.005% 1/17/2025 SG Americas Securities LLC9,653$210K0.0%+9.2%0.033% 11/19/2024 Barclays PLC41,684$1.14M0.0%+390.5%0.141% 11/16/2024 Geode Capital Management LLC485,121$13.29M0.0%-2.8%1.639% 11/15/2024 Barclays PLC41,684$1.14M0.0%+390.5%0.141% 11/15/2024 Jane Street Group LLC20,316$556K0.0%N/A0.069% 11/15/2024 Wellington Management Group LLP53,785$1.47M0.0%N/A0.182% 11/15/2024 State Street Corp821,131$22.48M0.0%+101.4%2.774% 11/15/2024 Point72 Asset Management L.P.437,700$11.98M0.0%+151.3%1.479% 11/15/2024 Janus Henderson Group PLC949,334$25.94M0.0%+40.5%3.207% 11/15/2024 HighVista Strategies LLC19,808$542K0.2%N/A0.067% 11/15/2024 Point72 Asia Singapore Pte. Ltd.8,568$235K0.0%-78.3%0.029% 11/14/2024 Fred Alger Management LLC9,633$264K0.0%+52.5%0.033% Hedge fund legend humiliates Bitcoin traders (Ad)Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities.Now he’s revealing the entire thing… FREE.11/14/2024 Braidwell LP493,687$13.52M0.4%+34.6%1.668% 11/14/2024 Vestal Point Capital LP395,000$10.82M0.8%-34.2%1.335% 11/14/2024 Walleye Capital LLC30,000$821K0.0%N/A0.101% 11/14/2024 MetLife Investment Management LLC13,939$382K0.0%+129.1%0.047% 11/13/2024 Great Point Partners LLC275,000$7.53M2.2%-63.7%0.929% 11/13/2024 FMR LLC4,403,148$120.56M0.0%+0.0%14.876% 11/12/2024 Charles Schwab Investment Management Inc.165,929$4.54M0.0%+142.0%0.565% 11/7/2024 Quest Partners LLC1,125$31K0.0%+112,400.0%0.004% 10/3/2024 SG Americas Securities LLC8,839$242K0.0%+104.0%0.030% 9/16/2024 Cubist Systematic Strategies LLC20,976$543K0.0%-13.1%0.071% (Data available from 1/1/2016 forward) DNTH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DNTH shares? During the previous two years, 79 institutional investors and hedge funds held shares of Dianthus Therapeutics. The most heavily invested institutionals were FMR LLC ($96.78M), Avidity Partners Management LP ($62.63M), Bain Capital Life Sciences Investors LLC ($58.64M), RA Capital Management L.P. ($52.00M), Octagon Capital Advisors LP ($42.48M), TCG Crossover Management LLC ($32.74M), and Vestal Point Capital LP ($30.84M).Learn more on Dianthus Therapeutics' institutional investors. What percentage of Dianthus Therapeutics' stock is owned by institutional investors? 47.53% of Dianthus Therapeutics' stock is owned by institutional investors. Learn more on DNTH's institutional investor holdings. Which institutional investors have been buying Dianthus Therapeutics' stock? Of the 65 institutional investors that purchased Dianthus Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($3.33M), Bain Capital Life Sciences Investors LLC ($2.99M), FMR LLC ($2.26M), TCG Crossover Management LLC ($1.50M), Vestal Point Capital LP ($1.44M), Avidity Partners Management LP ($1.22M), and Braidwell LP ($839.74K). How much institutional buying is happening at Dianthus Therapeutics? Institutional investors have bought a total of 8,133,864 shares in the last 24 months. This purchase volume represents approximately $177.88M in transactions. Which of Dianthus Therapeutics' major shareholders have been selling company stock? Of the 33 institutional investors that sold Dianthus Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Braidwell LP ($831.23K), Great Point Partners LLC ($482.93K), RA Capital Management L.P. ($466.60K), Point72 Asset Management L.P. ($422K), Bain Capital Life Sciences Investors LLC ($323.72K), Vestal Point Capital LP ($205K), and 5AM Venture Management LLC ($203.91K). How much institutional selling is happening at Dianthus Therapeutics? Institutional investors have sold a total of 3,824,830 shares in the last 24 months. This volume of shares sold represents approximately $83.77M in transactions. Related Companies Apellis Pharmaceuticals Major Shareholders NewAmsterdam Pharma Major Shareholders Bausch Health Companies Major Shareholders Arrowhead Pharmaceuticals Major Shareholders Denali Therapeutics Major Shareholders Twist Bioscience Major Shareholders Vericel Major Shareholders Kiniksa Pharmaceuticals Major Shareholders Agios Pharmaceuticals Major Shareholders Sarepta Therapeutics Major Shareholders This page (NASDAQ:DNTH) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dianthus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dianthus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
